Short-term outcomes of aflibercept biosimilar SB15 in macular edema secondary to retinal vein occlusion

Authors

Institutions

Publication Details

Journal
BMC Ophthalmology
Published
2026-03-07
DOI
https://doi.org/10.1186/s12886-026-04683-2
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-term outcomes of aflibercept biosimilar SB15 in macular edema secondary to retinal vein occlusion

Jae Hui Kim, Jaejin Cho, Chul Gu Kim, Sang Mok Park
BMC Ophthalmology
Retinal Diseases and Treatments
article

Short-term outcomes of aflibercept biosimilar SB15 in macular edema secondary to retinal vein occlusion

Jae Hui Kim, Jaejin Cho, Chul Gu Kim, Sang Mok Park
article en

Abstract

No abstract available for this paper.
BMC Ophthalmology
Kim's Eye Hospital (KR)
Zero hunger
Openalex Percentile: Top 30%
Retinal Diseases and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Short-term outcomes of aflibercept biosimilar SB15 in macular edema secondary to retinal vein occlusion — Jae Hui Kim, Jaejin Cho, et al. · BMC Ophthalmology (2026) | TGRS Research Map | TGRS